FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896585861> ?p ?o ?g. }

• W2896585861 abstract "Concurrent chemoradiotherapy (CCRT) is an effective first-line treatment for esophageal squamous cell carcinoma (ESCC). The present study aimed to compare clinical outcomes between three nedaplatin-based regimens for CCRT of ESCC. Patients with stage II-III thoracic ESCC in China between January 2012 and May 2016 were included. Patients received esophageal ultrasonography prior to treatment. Chemotherapy was as follows: i) 100 mg/m2 nedaplatin intravenously on day 1 and 70 mg/m2 tegafur-gimeracil-oteracil potassium (S-1) orally twice daily for 2 weeks; ii) 50 mg/m2 nedaplatin intravenously on days 1 and 2 and 35 mg/m2 docetaxel intravenously on days 1 and 8; or iii) 60 mg/m2 nedaplatin intravenously on days 1 and 2. Intensity-modulated radiotherapy was used to administer a total dose of 60-66 Gy (1.8-2.0 Gy per fraction) to the primary tumor and 45-50 Gy to the subclinical region. A total of 70 patients were enrolled (median age, 66 years; range, 50-81 years). T4 disease was identified in 45 (64.3%) patients. All patients completed radiotherapy and received ≥2 chemotherapy cycles. Estimated 1-, 2- and 3-year overall survival (OS) rates were 82.9, 53.9 and 31.4%, respectively. OS and progression-free survival were similar between the three treatment groups. Grade 3/4 hematological toxicities were observed in 35 (50%) patients. The incidence of serious treatment-associated toxicities was numerically highest for the nedaplatin/docetaxel combination. Patients with thoracic ESCC had good clinical outcomes following CCRT. With similar survival rates and disease responses yet lower hematological toxicities, nedaplatin/S-1 and single-agent nedaplatin may be preferable to nedaplatin/docetaxel. Poor control of distant metastasis may be a disadvantage of single-agent chemotherapy use in CCRT, and a further study with larger cohorts is required to confirm this." @default.
• W2896585861 created "2018-10-26" @default.
• W2896585861 creator A5004713760 @default.
• W2896585861 creator A5032000727 @default.
• W2896585861 creator A5036972504 @default.
• W2896585861 creator A5039334635 @default.
• W2896585861 creator A5056605850 @default.
• W2896585861 creator A5056736359 @default.
• W2896585861 creator A5082676682 @default.
• W2896585861 date "2018-10-10" @default.
• W2896585861 modified "2023-10-16" @default.
• W2896585861 title "Nedaplatin‑based chemotherapy regimens combined with concurrent radiotherapy as first‑line treatment for stage II‑III esophageal squamous cell carcinoma" @default.
• W2896585861 cites W1946726115 @default.
• W2896585861 cites W1968041240 @default.
• W2896585861 cites W1974545655 @default.
• W2896585861 cites W1975530023 @default.
• W2896585861 cites W2008190193 @default.
• W2896585861 cites W2008575122 @default.
• W2896585861 cites W2018187578 @default.
• W2896585861 cites W2019607817 @default.
• W2896585861 cites W2023272328 @default.
• W2896585861 cites W2032540605 @default.
• W2896585861 cites W2037231595 @default.
• W2896585861 cites W2050506271 @default.
• W2896585861 cites W2058153355 @default.
• W2896585861 cites W2067682297 @default.
• W2896585861 cites W2077902459 @default.
• W2896585861 cites W2087700319 @default.
• W2896585861 cites W2088175510 @default.
• W2896585861 cites W2117223681 @default.
• W2896585861 cites W2133046702 @default.
• W2896585861 cites W2133944806 @default.
• W2896585861 cites W2135790369 @default.
• W2896585861 cites W2136439667 @default.
• W2896585861 cites W2144263975 @default.
• W2896585861 cites W2146009402 @default.
• W2896585861 cites W2151969982 @default.
• W2896585861 cites W2167717055 @default.
• W2896585861 cites W2170898453 @default.
• W2896585861 cites W2221837786 @default.
• W2896585861 cites W2268572259 @default.
• W2896585861 cites W2317192938 @default.
• W2896585861 cites W2333908381 @default.
• W2896585861 cites W2500755615 @default.
• W2896585861 cites W2528623244 @default.
• W2896585861 cites W2552639339 @default.
• W2896585861 cites W2587622738 @default.
• W2896585861 cites W3143082516 @default.
• W2896585861 cites W4236554935 @default.
• W2896585861 cites W2035259377 @default.
• W2896585861 cites W2160251780 @default.
• W2896585861 doi "https://doi.org/10.3892/ol.2018.9564" @default.
• W2896585861 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6313161" @default.
• W2896585861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30655806" @default.
• W2896585861 hasPublicationYear "2018" @default.
• W2896585861 type Work @default.
• W2896585861 sameAs 2896585861 @default.
• W2896585861 citedByCount "7" @default.
• W2896585861 countsByYear W28965858612020 @default.
• W2896585861 countsByYear W28965858612021 @default.
• W2896585861 countsByYear W28965858612022 @default.
• W2896585861 crossrefType "journal-article" @default.
• W2896585861 hasAuthorship W2896585861A5004713760 @default.
• W2896585861 hasAuthorship W2896585861A5032000727 @default.
• W2896585861 hasAuthorship W2896585861A5036972504 @default.
• W2896585861 hasAuthorship W2896585861A5039334635 @default.
• W2896585861 hasAuthorship W2896585861A5056605850 @default.
• W2896585861 hasAuthorship W2896585861A5056736359 @default.
• W2896585861 hasAuthorship W2896585861A5082676682 @default.
• W2896585861 hasBestOaLocation W28965858611 @default.
• W2896585861 hasConcept C126322002 @default.
• W2896585861 hasConcept C141071460 @default.
• W2896585861 hasConcept C143998085 @default.
• W2896585861 hasConcept C2776694085 @default.
• W2896585861 hasConcept C2777299880 @default.
• W2896585861 hasConcept C2778203143 @default.
• W2896585861 hasConcept C2778239845 @default.
• W2896585861 hasConcept C2778424827 @default.
• W2896585861 hasConcept C2781190966 @default.
• W2896585861 hasConcept C509974204 @default.
• W2896585861 hasConcept C71924100 @default.
• W2896585861 hasConcept C90924648 @default.
• W2896585861 hasConceptScore W2896585861C126322002 @default.
• W2896585861 hasConceptScore W2896585861C141071460 @default.
• W2896585861 hasConceptScore W2896585861C143998085 @default.
• W2896585861 hasConceptScore W2896585861C2776694085 @default.
• W2896585861 hasConceptScore W2896585861C2777299880 @default.
• W2896585861 hasConceptScore W2896585861C2778203143 @default.
• W2896585861 hasConceptScore W2896585861C2778239845 @default.
• W2896585861 hasConceptScore W2896585861C2778424827 @default.
• W2896585861 hasConceptScore W2896585861C2781190966 @default.
• W2896585861 hasConceptScore W2896585861C509974204 @default.
• W2896585861 hasConceptScore W2896585861C71924100 @default.
• W2896585861 hasConceptScore W2896585861C90924648 @default.
• W2896585861 hasLocation W28965858611 @default.
• W2896585861 hasLocation W28965858612 @default.
• W2896585861 hasLocation W28965858613 @default.
• W2896585861 hasLocation W28965858614 @default.
• W2896585861 hasOpenAccess W2896585861 @default.
• W2896585861 hasPrimaryLocation W28965858611 @default.

• next